Literature DB >> 2024451

DNA-ploidy and survival in gastric carcinomas: a flow-cytometric study.

G Baretton1, O Carstensen, M Schardey, U Löhrs.   

Abstract

In 125 gastric carcinomas the nuclear DNA content was determined by flow cytometry from formalin-fixed and paraffin-embedded tissue of surgical specimens. The carcinomas were of intestinal or mixed type (85), and diffuse type (40). DNA-aneuploidy was found in 46% of the intestinal type and in 42% of the mixed type, but only in 15% of the diffuse-type carcinomas (P less than 0.01). The total rate of DNA-aneuploidy was 34%. Carcinomas localized in the cardia were more frequently DNA-aneuploid than tumours in other localizations (P less than 0.01). DNA-aneuploid carcinomas had metastasized more frequently to regional lymph nodes (P less than 0.05) whereas no correlations with tumour stage and cytological/histological grade were detected. In 94 patients follow-up data were available. DNA-aneuploidy was associated with a statistically significant poorer prognosis when compared to DNA-diploid tumours only in advanced gastric carcinomas with lymph node metastases (P = 0.0488) and in the subgroup of advanced intestinal and mixed-type tumours (P = 0.0289).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2024451     DOI: 10.1007/bf01600158

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  38 in total

1.  Gastric carcinoma. A pathobiological classification.

Authors:  S C Ming
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860

2.  Preoperative detection of a highly malignant type of early gastric carcinoma by cytophotometric DNA analysis.

Authors:  T Kamegawa; T Okamura; K Sugimachi; K Inokuchi
Journal:  Jpn J Surg       Date:  1986-05

3.  Flow cytometry: a high-resolution instrument for everyone.

Authors:  H B Steen; T Lindmo
Journal:  Science       Date:  1979-04-27       Impact factor: 47.728

4.  [Comparative flow cytometry analysis of DNA and CEA in stomach carcinoma].

Authors:  W Mellin; P Davaris; W Jütte; G Heidl; V Krieg; E Grundmann
Journal:  Verh Dtsch Ges Pathol       Date:  1986

Review 5.  Tumor heterogeneity.

Authors:  G H Heppner
Journal:  Cancer Res       Date:  1984-06       Impact factor: 12.701

Review 6.  Flow cytometry in clinical cancer research.

Authors:  B Barlogie; M N Raber; J Schumann; T S Johnson; B Drewinko; D E Swartzendruber; W Göhde; M Andreeff; E J Freireich
Journal:  Cancer Res       Date:  1983-09       Impact factor: 12.701

7.  Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance.

Authors:  D W Hedley; M L Friedlander; I W Taylor
Journal:  Cytometry       Date:  1985-07

8.  Flow cytometry as a predictive indicator in patients with operable gastric cancer.

Authors:  D M Nanus; D P Kelsen; D Niedzwiecki; D Chapman; M Brennan; E Cheng; M Melamed
Journal:  J Clin Oncol       Date:  1989-08       Impact factor: 44.544

9.  Cellular DNA content and metastasis pattern in colorectal carcinomas.

Authors:  C Rübe; G Valet; M Eder
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

Review 10.  [The epidemiology of gastric cancer (author's transl)].

Authors:  C J Pfeiffer
Journal:  Leber Magen Darm       Date:  1976
View more
  4 in total

Review 1.  Clinical aspect and molecular mechanism of DNA aneuploidy in gastric cancers.

Authors:  Eiji Oki; Yuichi Hisamatsu; Koji Ando; Hiroshi Saeki; Yoshihiro Kakeji; Yoshihiko Maehara
Journal:  J Gastroenterol       Date:  2012-03-09       Impact factor: 7.527

2.  DNA ploidy and biologic aggressiveness of gastric adenocarcinoma in Chinese.

Authors:  K L Shen; C H Chu
Journal:  World J Surg       Date:  1994 May-Jun       Impact factor: 3.352

3.  DNA ploidy in early gastric carcinoma (T1): a flow cytometric study of 100 European cases.

Authors:  M J Brito; M I Filipe; G T Williams; H Thompson; M G Ormerod; J Titley
Journal:  Gut       Date:  1993-02       Impact factor: 23.059

4.  Prognostic value of DNA flow cytometry in stomach cancer: a 5-year prospective study.

Authors:  K H Lee; J S Lee; J H Lee; S W Kim; C Suh; W K Kim; S H Kim; Y I Min; B S Kim; K C Park; M S Lee; H S Sun
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.